Cerevel Therapeutics Holdings, Inc.
NASDAQ:CERE
44.96 (USD) • At close July 31, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2015 | 2014 | 2013 | 2012 | 2001 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||
| Current Assets: | ||||||||||
| Cash & Cash Equivalents
| 990.965 | 136.521 | 193.018 | 383.623 | 79.551 | 8.095 | 3.423 | 8.881 | 21.069 | -117.802 |
| Short Term Investments
| 574.5 | 755.509 | 372.67 | 0 | 0 | 0 | 24.579 | 21.63 | 33.565 | 0 |
| Cash and Short Term Investments
| 990.965 | 892.03 | 565.688 | 383.623 | 79.551 | 8.095 | 28.002 | 30.511 | 54.634 | -117.802 |
| Net Receivables
| 5.291 | 2.046 | 0.729 | 0 | 0 | 0.577 | 0.37 | 0.957 | 0.765 | 0 |
| Inventory
| 0 | -2.046 | -0.729 | 0 | 0 | 0 | 0.084 | 0.02 | 0.841 | 0 |
| Other Current Assets
| 10.682 | 13.621 | 12.329 | 6.937 | 0.069 | 1.094 | 0.873 | 0.948 | 1.328 | 0 |
| Total Current Assets
| 1,006.938 | 905.651 | 578.017 | 390.56 | 87.077 | 9.766 | 29.329 | 32.436 | 57.568 | -117.802 |
| Non-Current Assets: | ||||||||||
| Property, Plant & Equipment, Net
| 45.772 | 49.287 | 51.7 | 48.624 | 27.491 | 1.258 | 2.996 | 4.633 | 5.756 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 187.159 | 58.126 | 52.269 | 4.2 | 0 | 0 | 24.579 | 21.63 | 5.72 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 88.031 | 0 |
| Other Non-Current Assets
| 3.429 | 4.758 | 6.933 | 1.889 | 6.238 | -9.668 | -53.809 | -53.957 | -87.828 | 0 |
| Total Non-Current Assets
| 236.36 | 112.171 | 110.902 | 54.713 | 33.729 | -8.41 | -26.234 | -27.694 | 11.679 | 0 |
| Total Assets
| 1,243.298 | 1,017.822 | 688.919 | 445.273 | 120.806 | 1.356 | 3.095 | 4.742 | 69.247 | -117.802 |
| Liabilities & Equity: | ||||||||||
| Current Liabilities: | ||||||||||
| Account Payables
| 11.863 | 10.061 | 11.298 | 4.993 | 2.109 | 4.402 | 4.278 | 3.825 | 5.476 | 0 |
| Short Term Debt
| 3.404 | 2.899 | 2.437 | 2.036 | 2.592 | 0 | 0 | 0 | 0.134 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 28.428 | 22.246 | 10.101 | 0 | 0.356 | 0 | 0.701 | 0 |
| Other Current Liabilities
| 76.912 | 59.604 | 0.375 | 0.273 | 0.074 | 0.82 | 0.088 | 0.172 | 0.031 | 0 |
| Total Current Liabilities
| 92.179 | 72.564 | 42.538 | 29.548 | 14.876 | 5.222 | 4.722 | 3.997 | 6.342 | 0 |
| Non-Current Liabilities: | ||||||||||
| Long Term Debt
| 449.588 | 366.672 | 34.11 | 30.969 | 25.819 | 4.402 | 4.278 | 3.825 | 0.256 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.088 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 27.786 | 57.348 | 33.542 | 0.236 | 2.288 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 477.374 | 424.02 | 67.652 | 31.205 | 28.107 | 4.402 | 4.278 | 3.825 | 0.344 | 0 |
| Total Liabilities
| 569.553 | 496.584 | 110.19 | 60.753 | 42.983 | 6.909 | 4.815 | 4.172 | 6.686 | 0 |
| Equity: | ||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0.018 | 0.016 | 0.015 | 0.013 | 0.006 | 1.631 | 0.482 | 0.248 | 0.245 | 0 |
| Retained Earnings
| -1,400.597 | -967.755 | -616.244 | -390.91 | -244.298 | 0 | 0 | 0 | -242.073 | 0 |
| Accumulated Other Comprehensive Income/Loss
| 1.771 | 3.097 | -0.986 | 0 | 0 | 0.762 | -0.595 | -0.696 | -0.283 | 0 |
| Other Total Stockholders Equity
| 2,072.553 | 1,485.88 | 1,195.944 | 775.417 | 322.115 | 1.82 | 27.722 | 33.454 | 304.672 | 0 |
| Total Shareholders Equity
| 673.745 | 521.238 | 578.729 | 384.52 | 77.823 | 4.213 | 27.609 | 33.006 | 62.561 | 0 |
| Total Equity
| 673.745 | 521.238 | 578.729 | 384.52 | 77.823 | 4.213 | 27.609 | 33.006 | 62.561 | 0 |
| Total Liabilities & Shareholders Equity
| 1,243.298 | 1,017.822 | 688.919 | 445.273 | 120.806 | 1.356 | 3.095 | 4.742 | 69.247 | -117.802 |